 |
1.Hepatitis E vaccine development: A 14 year odyssey. Wu T, Li SW, Zhang J, Ng MH, Xia NS, Zhao Q. Hum Vaccin Immunother. 2012 Jun 1;8(6). [Epub ahead of print] 影响因子： 暂无
2.Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients. Yuan Q, Song LW, Liu CJ, Li Z, Liu PG, Huang CH, Yan Y, Ge SX, Wang YB, Peng CY, Zhang J, Kao JH, Chen DS, Chen PJ, Xia NS. Gut. 2012 Jun 14. [Epub ahead of print] No abstract available. 影响因子： 10.614
3.Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity. Zhang J, Li SW, Wu T, Zhao Q, Ng MH, Xia NS. Rev Med Virol. 2012 May 30. doi: 10.1002/rmv.1719. [Epub ahead of print] 影响因子： 5.6
4.Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia NS. J Hepatol. 2012 May 23. [Epub ahead of print] 影响因子： 9.334
5.The enhancement of RNAi against HIV in vitro and in vivo using H-2K(k) protein as a sorting method. Gu Y, Hou W, Xu C, Li S, Shih JW, Xia N. J Virol Methods. 2012 Jun;182(1-2):9-17. Epub 2012 Mar 1. 影响因子： 2.139
6.Hepatitis E Nassim Kamar , Richard Bendall, Florence Legrand-Abravanel , Ning-Shao Xia , Samreen Ijaz , Jacques Izopet ，Harry R Dalton The Lancet, Volume 379, Issue 9835, Pages 2477 - 2488, 30 June 2012 影响因子： 33.633
厦门大学南强论坛www.xmubbs.com
| |
